The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm
JAMA Intern Med
.
2020 Aug 1;180(8):1118-1119.
doi: 10.1001/jamainternmed.2020.1853.
Authors
Colette DeJong
1
,
Robert M Wachter
1
Affiliation
1
Department of Medicine, University of California, San Francisco.
PMID:
32347894
DOI:
10.1001/jamainternmed.2020.1853
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections* / drug therapy
Humans
Hydroxychloroquine*
Internet
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
United States
Substances
Hydroxychloroquine